Posters

Diode laser in treating secondary neovascular glaucoma

Poster Details

First Author: A. Egorov RUSSIAN FEDERATION

Co Author(s):    F. Nikolay   K. Dmitrii                 

Abstract Details

Purpose:

Evaluation of efficiency of diode laser in treating secondary neovascular glaucoma.

Setting:

City Clinical Hospital No 15 na OM Filatov, Moscow

Methods:

The study involved 18 patients (18 eyes), including men and women aged 51 to 64 years old, who had had occlusion of the central retinal vein and diagnosed with stage 2 neovascular glaucoma (NVG) (level of intraocular pressure (IOP) ranging from 27 to 35 mm hg, visualization of neovasculature detected with the use ofslit-lamp and gonioscopy lens). The patients were subjected to the sectoral modified diode cyclo coagulation with the ophtalmosurgical diode laser ALOD-01-'ALKOM' using infra-red rays.

Results:

The study showed that during the early postoperative period (5 days after the operation) the quantity of neovasculature was smaller and the IOP's level was 3-5 mm hg lower. A month after the sectoral modified diode cyclocoagulation there was no neovasculature detected by the slit-lamp and gonioscopy, the IOP's level was 7-10 mm hg lower. After the operation the patients were prescribed to take sol. Nepafenaci 0,1% (1 drop three times a day) during 4 weeks.In the course of observation in postoperative period the first day after the operation in 2 cases there was a conjunctive irritation that was corrected in 3 days due to the anti-inflammatory therapy (sol. Nepafenaci 0,1%, 1 drop three times a day).

Conclusions:

The study showed that the use of the diode laser in treating secondary neovascular glaucoma is a perspective method that corrects the problem of neovasculature at minimum risk of development of complications during the postoperative period.

Financial Disclosure:

NONE